However, our data suggest that increased SGLT2 induction by Ang II plays no role in hypertension development, as demonstrated by the observation that SGLT2 inhibition by Empagliflozin did not affect hypertension development during Ang II infusion. This evidence concerns the gene SLC5A2 and Hypertension.